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ABSTRACT 
OBJECTIVE 
To evaluate feasibility of percutaneous nephrolithotomy (PCNL) for complex nephrolithiasis in 
patients 80 years of age and older compared to younger individuals. 
METHODS 
From an institutional IRB-approved database, 1,647 patients were identified who underwent 
PCNL from 1999 to 2019. Patients were stratified by age: group 1 (20-59), group 2 (60-79), and 
group 3 (>80). Statistics were performed using chi-square and ANOVA to compare outcomes. 
RESULTS 
Of the 1,647 patients, median age was 46, 66, and 83, respectively (P <0.0001). Three 
patients within group 3 were 90 or older. Females made up 54%, 46%, 56% of patients (P = 
0.02). Average stone size with SD was 2.6 ± 2.2, 2.5 ± 2.3, 2.2± 1.9 cm for each group (P = 
0.06). Mean preoperative hemoglobin (Hgb) was significantly lower in the 80+ group (13.8, 
13.4, 13.1 g/dL, P <.0001). Change in Hgb was not significantly different. There were more 
Clavien II-IV complications (10.4, 14.4, 28.8%; P = 0.02) and transfusions (2.3, 4.7, 10.2%; P 
<0.001) in the elderly. The most common complications in the 80+ group were bleeding related 
(10.1%). No difference in readmission rates or ICU admissions was noted. 
CONCLUSION 
PCNL is feasible in the extremely elderly; however with a higher rate of complications and 
longer hospitalizations. No long-term sequelae or deaths in the 80 and older cohort were seen. 
This study allows us to appropriately counsel older patients on a realistic postoperative course 
and supports use of PCNL as the best means of long-term survival. 
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Since the introduction of percutaneous nephrolithotomy (PCNL) as a method of treating 
complex renal stones, open surgery to treat nephrolithiasis has essentially been 
replaced.1, 2 In the setting of large stone disease, atypical genitourinary anatomy, and 
infectious stones, PCNL is considered the standard of care.3, 4, 5 With both an increase 
in life expectancy and in surgical procedures performed in the elderly, the need for 
understanding operative risk of PCNL in older patients is understood.9, 10 Standard risks 
of PCNL include infection, hemorrhage requiring transfusion, intrarenal or retroperitoneal 
hematoma or urinoma, prolonged nephrostomy tube or ureteral stenting, and injury to 
surrounding organs and additional anesthetics for secondary 
procedures.6, 7, 8 Increasing age has even been associated with an increase in blood 
transfusion risk.11 Multivariate analysis has suggested that increased age is both an 
independent predictor of postoperative complications and associated with increased 
mortality during hospitalization.4 Literature has nonetheless demonstrated that with the 
expertise of an experienced surgeon, PCNL can be safely performed as patient age 
exceeds 60, 65, and even 70 years old.12, 13, 14 
It is well accepted that advances in age are associated with increases in comorbidities. 
Despite only 2% of the US population being 80 or older, there are multiple occurrences 
of complex stone disease in octogenarians. Therefore, as our urologic advancements 
continue to minimize the operative trauma associate with percutaneous stone surgery, 
we remain compelled to evaluate the safety of PCNL and its efficacy in very elderly 
patients. The purpose of this study is to evaluate our institutional experience and compare 
outcomes and complications of PCNL in patients 80 years and older compared to their 
younger cohorts. 
METHODS 
This is a retrospective study of patient records from our IRB-approved collected PCNL 
database for patients in the Department of Urology at Methodist Hospital which is part of 
Indiana University/IU Health. The eligibility criteria included patients who underwent 
PCNL for upper urinary tract stone disease between 1999 and 2019 and who gave 
consent for their medical records to be utilized for research purposes. Exclusion criteria 
 
 
included patients with active bleeding diatheses, patients under 18 years of age, and 
those who were pregnant. 
All patients (n = 1647) in the PCNL database were examined preoperatively including 
medical histories for comorbidities, physical examination to assess body habitus, 
standard imaging (CT scan), and urine culture. Patients underwent prone PCNL using 
fluoroscopic guidance; access was obtained by the urologist in the operating room using 
triangulation technique. Percutaneous access tracts were balloon dilated to 
accommodate a 30 French sheath. Rigid and flexible nephroscopy were performed as 
needed. Ultrasonic and pneumatic lithotripsy were employed for most cases. Flexible 
nephroscopy was performed in all cases to assess the entire collecting system. For 
isolated calculi, holmium laser lithotripsy with basket extraction was utilized. All patients 
had a nephrostomy tube placed at the conclusion of the procedure, with or without an 
additional reentry catheter, overnight. Noncontrast CT scans were obtained on 
postoperative day one, with secondary procedures (repeat PCNL or ureteroscopy) 
following for patients with residual stone burden. Those without residual stones 
underwent a formal nephrostogram or methylene blue testing which was surgeon specific. 
Methylene blue testing involves injection of the dye into the nephrostomy tube. Blue, 
green discoloration of the patients urine within the urinary catheter tubing within 15 
minutes of methylene blue administration signaled a successful demonstration of 
antegrade ureteral flow. In the setting of a normal nephrostogram or successful methylene 
blue test, the nephrostomy tube was removed along with the transurethral urinary 
catheter. Patients were discharged on postoperative day one, unless they underwent a 
secondary procedure. Follow-up clinic visits were scheduled between 6 and 12 weeks, 
with an US and KUB at 6 weeks postprocedure. 
Pertinent baseline and preoperative data and perioperative outcomes were collected. 
Baseline variables included patient demographics and comorbidities as well as details 
about the stone size and location. Perioperative outcome variables included laboratory 
values, complications using the Clavien classification system within 30 days of the 
surgical procedure, transfusion rates, length of stay, and presence of a drainage tube at 
time of discharge. 
 
 
Data were statistically analyzed using the SPSS statistical software package. Patients 
were stratified into 3 groups based on age: 20-59, 60-79, and 80+ years old. The decision 
to stratify into 3 groups was based on established increased risk of complications and 
hospitalization lengths with age.4 Frequencies and descriptive statistics including the 
mean and standard deviations were reported. The Pearson chi-square test and ANOVA 
statistical tests were used to compare outcomes between the 80+ and younger cohort 
groups. 
RESULTS 
In Table 1, the baseline characteristics of the 1,647 patients are shown. Preoperatively, 
there were significantly higher number of patients with diabetes (17% for 20-59, 28% for 
60-79, and 22% for 80+, P <.001) and hypertension (35% for 20-59, 54% for 60-79, and 
51% for 80+, P <0.001) in the 65 to 79-year-old group as compared to the other groups 
(Table 1). Mean preoperative hemoglobin (Hgb) was significantly lower in the 80 and over 
group when compared to the other 2 groups (13.8 for 20-59, 13.4 for 60-79, and 13.1 g/dL 
for 80+, P <.0001). Mean serum creatinine was highest in the 65 to 79-year-old and 80+ 
years old group (1.1 for 20-59, 1.2 for 65-79, 1.2 for 80+, P <.001). Intraoperative 
characteristics including access details, stone composition, and positive culture rates are 
reported in Table 2. The octogenarian population had greater rates of calcium oxalate, 
hydroxyapatite, and brushite stones as well as lower rates of uric acid, cystine, struvite, 
and “other” stone compositions with an overall statistically significant difference in stone 
analysis (P = .003). 
The percent of patients with postoperative complications was highest in the 80+ group 
(28.8% vs 14.4%—group 2 and 10.4%—group 1). Table 3 reports full details on 
complication rates; there were more Clavien II-IV complications in the 80+ cohort 
compared to other age groups. The most common Clavien II complication in the 80+ 
group was acute blood loss requiring transfusion. The Clavien III complication seen most 
often was respiratory distress. Sepsis was the most severe Clavien IV complication 
suffered by a single 80+ patient. The transfusion rate was also highest in the 80+ age 
 
 
group (2.3% for 20-69, 4.8% for 60-79, 10.2% for 80+, P <.001). The most common 
overall complication in the 80+ group was bleeding complications (11%) requiring clot 
evacuation (1.7%), pseudoaneursym embolization (1.7%), and double J-stent placement 
for clot-related colic (1.7%). There was no statistically significant difference in change 
from pre- to postoperative hemoglobin among the groups. The length of stay was longer 
in the 80+ group (2.3 days for 20-59, 2.7 days for 60-79, 3.0 days for 80+, P <.01). 
However, no difference in readmission rates or ICU admissions was noted between 
groups. There was one death noted in the 65-79 years of age cohort, which occurred in 
a 71-year-old man with bilateral staghorn calculi in a shoehorn kidney who was found 




This study demonstrates that PCNL in the aging population, specifically 80 years of age 
and older, is a safe and effective surgical treatment for complex nephrolithiasis. Patients 
over the age of 80 years are likely to present with anemia or renal insufficiency compared 
to their younger counterparts. Postoperatively, the 80+ group of patients demonstrated 2-
 
 
3 times and 2-4 times greater risk of having a complication or needing a blood transfusion. 
However, no difference was seen in ICU admission or readmission rates between age 
groups. 
As our population ages a number of groups have sought to explore the outcomes of PCNL 
in older populations. Both Sahin and Buldu et al looked at patients 60 and older and how 
their patients fared compared to younger patients. They found that 66% and 88% of their 
older cohort had a comorbidity such as hypertension, diabetes mellitus, or chronic 
obstructive pulmonary disorder9 which is similar to our experience where 65% of patients 
80 years of age and older had hypertension, diabetes, and/or renal insufficiency. 
Metabolic syndrome is also an increasing issue and is associated with renal stone 
development. Even in our 80+ patients BMIs ranged up to 35 with an average of 26.2 
making the cohort overweight.15 Despite high rates of patient comorbidities, 55% of the 
patients 80 years and older had a postoperative CT without stones, no complications, and 
were discharged with an average stay of 2 days. 
When looking at overall stone free rates after secondary procedures for residual stones, 
we found that 72.7% of our octogenerians were stone-free which was lower than our 
younger 2 cohorts (81.9% in 20-59, 82.9% in 60-79, P = .02), a comparable finding to 
previous publications. Morganstern et al showed similarly that in older patients SFRs were 
lesser than their younger counter parts (82% in <65, 78% in >80, P = .23). Compared to 
our younger cohort, the frequency of stone compositions did differ amongst the groups. 
This is especially interesting that despite more comorbidities, there were not higher rates 
of infectious stones. The importance of this study highlights a similar conclusion of the 
1973 sentinal paper by Singh et al (Singh M, Chapman R, Tresidder GC, Blandy J. The 
fate of the unoperated staghorn calculus. BJU Int. 1973) in suggesting that age alone 
should not deter us from percutaneous stone surgery and that when safe the best option 
for long-term survival is to surgically remove large kidney stones. 
In Nakamon et al's study they assessed the safety and efficacy of PCNL in patients older 
than 65 and reported a complication rate of 13.1% in their elderly population with a 
significantly higher rate of sepsis.13 Anagnostu's et al observed a complication rate of 
14.1% in their elderly group, defined as 70 and older, with one patient dying in the 
 
 
postoperative period due to a PCNL-related complication.14 One study showed PCNL in 
octogenarians was feasible with a 36% complication which is similar to our finding 25.9% 
complication rate; however, they did not find this to be significantly different than their 
younger control group.16 The results herein demonstrate that with increasing age past 80, 
the risk of complications of with PCNL also increase. However, no patients 80 years of 
age or older in our current study suffered long-term sequalae and no deaths were 
observed. 
The results of our current study must be viewed in the context of certain limitations. This 
retrospective review here does not have the benefit of being a randomized control trial. 
Nonetheless, this is, to our knowledge, the largest report on patients over the age of 80 
years undergoing PCNL and their relative risks of surgery. Furthermore, the increased 
risk of bleeding seen in our elderly population of interest may be due to a higher incidence 
of anticoagulation and baseline anemia within the cohort. Future work will address 
whether there is an association between those factors. Finally, there is likely variance due 
to the wide range of years that our patients underwent surgery. However, some of the 
variation is mitigated by the study being high volume, over 1500 patients, at a single 
institution. 
These limitations notwithstanding, the current study provides support to the use of PCNL 
in the extreme aging patient population. It can be a safe and effective treatment method 
for renal stones when understood that there may be an increased risk of complications, 
namely blood loss requiring transfusion. Previous literature has detailed the efficacy of 
PCNL for elderly patients, but as life expectancy continues to increase there is a need to 
explore the question for patients over the age of 80 years. 
CONCLUSION 
Percutaneous nephrolithotomy is feasible in patients 80 years of age and older. Our 
results demonstrate the procedure to be relatively safe and effective in this extreme aging 
population, while acknowledging that these patients have higher rates of complications, 
particularly bleeding requiring transfusion. We reported no deaths or long-term sequelae 
in our 80+ PCNL cohort. After hematologic risks are considered, PCNL offers the best 
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